RA Capital — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Spero TherapeuticsinNASDAQ: SPROMar 2017
BiotechCambridge, US
Patrick Vink(Director)Milind Deshpande(Director)Jean-Francois Formela(Director)Casper Breum(Director)Ankit Mahadevia(Executive Officer, Director)Stephen Garbacz(Executive Officer)
Board seatReza Halse· per SEC Form D
Antera TherapeuticsSep 2017SEC filingmedium confidence
HealthtechCambridge, US
Clarence Friedman(Executive Officer, Director)
Board seatPeter Kolchinsky· per SEC Form D · $3.1M raise · filed Sep 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.